Etacept (Etanercept PFS) 25mg/0.5ml

Etacept PFS 25mg/0.5ml is a pre-filled syringe containing etanercept, a TNF inhibitor used to manage inflammatory conditions. This biologic therapy helps reduce symptoms in autoimmune disorders by targeting specific immune pathways. Suitable for adults and certain pediatric patients under medical supervision.

Strength

25mg/0.5ml

Manufacturer / TM Owner

CIPLA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Etanercept is commonly used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. It is also prescribed for ankylosing spondylitis and juvenile idiopathic arthritis in appropriate cases. Patients often ask, 'what is Etacept used for' to understand its role in managing chronic inflammatory diseases.

Side Effects

Etanercept works by binding to tumor necrosis factor (TNF), a substance in the body that causes inflammation. This helps reduce joint pain, swelling, and stiffness in arthritis, as well as skin symptoms in psoriasis. Users may notice gradual improvement over weeks of consistent use.

Precautions & Warnings

Store Etacept PFS 25mg/0.5ml refrigerated between 2°C and 8°C and protect from light. Do not freeze or shake vigorously. Always check the solution for particles or discoloration before use. Dispose of used syringes in a sharps container as directed by healthcare guidelines.

Avoid Interactions

Etanercept may interact with other biologics or immunosuppressants, increasing infection risk. Live vaccines should be avoided during treatment. Inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to assess potential interactions.

Frequently Asked Questions

Symptom improvement may take several weeks of regular use. Individual responses vary based on condition and treatment plan.

Consult a healthcare provider. Limited data exists; risks and benefits should be evaluated before use.

Common effects may include injection site reactions, headaches, or upper respiratory infections. Report persistent issues to a doctor.

No, Etacept is a biologic therapy that targets specific immune pathways rather than a corticosteroid.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.